Sam-A Pharm Co Ltd
KOSDAQ:009300
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sam-A Pharm Co Ltd
Operating Income
Sam-A Pharm Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sam-A Pharm Co Ltd
KOSDAQ:009300
|
Operating Income
₩12.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Yuhan Corp
KRX:000100
|
Operating Income
₩104.4B
|
CAGR 3-Years
43%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Operating Income
₩203.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Operating Income
₩257.8B
|
CAGR 3-Years
18%
|
CAGR 5-Years
39%
|
CAGR 10-Years
2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Operating Income
₩8.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Operating Income
₩20.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Sam-A Pharm Co Ltd
Glance View
Sam-A Pharm.Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Wonju, Gangwon-Do. The company went IPO on 2000-07-19. Co., Ltd is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The firm's products include remedies for respiratory, antibiotics, dermatitis treatments, dyspeptic agents, cold remedies, antifebriles, antiphlogistics, analgesics, antihistamines, and remedies for the circulatory, gastrointestinal, urinary systems, cardiovascular and other general pharmaceuticals. The company also provides children nutrition products under the brand name of NOMA.
See Also
What is Sam-A Pharm Co Ltd's Operating Income?
Operating Income
12.2B
KRW
Based on the financial report for Sep 30, 2025, Sam-A Pharm Co Ltd's Operating Income amounts to 12.2B KRW.
What is Sam-A Pharm Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
8%
Over the last year, the Operating Income growth was -52%. The average annual Operating Income growth rates for Sam-A Pharm Co Ltd have been -11% over the past three years , 15% over the past five years , and 8% over the past ten years .
